120 likes | 178 Views
Administration of antagonist Brilliant Blue G (BBG) improves spinal cord injury recovery by blocking the P2X7 receptor, reducing motor neuron death and astrocyte changes caused by excess ATP. Experiments showed a significant improvement in walking ability in lab rats paralyzed by spinal cord injury. Results revealed the efficacy of BBG in promoting coordinated movements and plantar stepping. Comparisons highlight the positive impact of BBG treatment on motor function and recovery after spinal cord injury.
E N D
Use of Brilliant Blue G to Improve Recovery After a Spinal Cord Injury Administration of an antagonist of the ATP-sensitive receptor P2X7
Results of Spinal Cord Injury • Excess of Extracellular ATP • Activation of P2X7 acceptors • Change in astrocytes • Motor neuron death
Effects of Extracellular ATP • 1 Treatment– No Change • 2 Treatments – 27% Degradation • 3 Treatments – 36% Degradation
Activation of P2X7 Through Other Means • P2X7 agonist 2',3'-O-(4-benzoylbenzoyl)ATP(BzATP) used to activate P2X7 • 30% motor neuron attrition
Inhibition of P2X7 • Based on previous experiments using P2X7 agonists, researchers posited the use of an antagonist would block the phenotype change in the astrocytes. • OxATP • Brilliant Blue G(BBG) • Also known as FD&C Blue #1
Lab rats paralyzed by dropping a 10 gram weight from a height of 12.5 mm onto the spinal cord • Three test groups • Vehicle • 10 mg/kg • 50 mg/kg
Surprising Results • Treatment with BBG for 3 consecutive days • Regained ability to walk • Turned Eyes and Skin Blue!
Results at 42 Days BBG Treated Vehicle Treated • Movement of hind legs • Coordinated movement of front and rear legs • Ability to support plantar steps • Movement of hind legs • Not coordinated • Could not support plantar steps
Comparing results Untreated Treated